How Solomon was paid
$1.1M in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Other | Total |
|---|---|---|---|---|---|---|
| Jonathan SolomonChief Executive Officer | $415,103 | $50,689 | $49,798 | $460,921 | $102,081 | $1,078,592 |
| Marina WolfsonChief Financial Officer | $179,905 | — | — | $124,854 | $46,793 | $351,552 |
| Dr. Merav BassanChief Development Officer | $265,809 | $31,833 | $31,273 | $130,859 | $73,208 | $532,982 |
What changed and why
- $1.1M$1,078,592 was CEO total compensation in 2024, down from $1,118,541 in 2023.
- $461K$460,921 was the CEO’s 2024 option-award grant-date fair value.
- $49,798$49,798 was the CEO’s 2024 stock-award grant-date fair value for fully vested RSUs.
- 40%40%-50% of salary was the stated eligibility range for annual performance-based bonuses.
- 2024 bonuses were accrued after completion of the March 2024 private placement transaction.
- 2025 cash bonuses equal to three months’ salary were approved for Solomon and Wolfson, reducing severance entitlements.
Other BiomX proxy statements
- 2026 proxy statement
Jonathan Solomon paid $1.4M (+27% on the year).
Filed Jun 08, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.